This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Focus of Women's Mental Health

Female Reproductive Life Cycle and Hormones: Methodology to Improve Clinical Trials

Marlene P. Freeman, MD; Rosemary Walker, BA; Thomas P. Laughren, MD; Karen K. Miller ,MD; and Maurizio Fava, MD

Published: October 15, 2013

Article Abstract
Because this piece does not have an abstract, wehave provided for your benefit the first 3 sentences of the fulltext.

 

In clinical trials, there are 2 competing ethical priorities regarding the participation of women. One is that women of childbearing potential could become pregnant during a trial, raising concern over fetal exposure to an agent of unknown reproductive safety. The other is the need for development of treatments specific to subpopulations of patients in order to better inform care.

Volume: 74

Quick Links: Populations , Women

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...